Physiological Dead Space and Intensive Care Mortality in Mechanically Ventilated Patients

NCT ID: NCT06963944

Last Updated: 2025-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-04-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the relationship between physiological dead space and clinical outcomes, specifically mortality and discharge status, in adult patients receiving invasive mechanical ventilation in the intensive care unit (ICU). Physiological dead space refers to ventilated but non-perfused regions of the lungs and can be quantified using the Enghoff-modified Bohr equation based on capnographic and arterial CO₂ measurements.

While volumetric capnography is a valuable tool in anesthesiology and perioperative care, its use in ICU settings remains limited. By continuously monitoring physiological dead space at the bedside, this study aims to provide real-time insight into ventilation-perfusion mismatch and assess its prognostic significance in critically ill patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Physiological dead space is defined as the portion of tidal volume that does not participate in effective gas exchange. It includes both anatomical and alveolar components and is a dynamic marker influenced by pulmonary perfusion, airway patency, ventilation settings, and lung pathology. In critically ill patients, particularly those receiving invasive mechanical ventilation, monitoring dead space may provide valuable insight into disease severity, ventilation-perfusion mismatch, and the adequacy of mechanical ventilation.

While capnography is routinely used in operating rooms and during anesthesia management, its role in intensive care units (ICUs) remains underutilized. Volumetric capnography offers a non-invasive, continuous method for assessing expired CO₂ and evaluating respiratory physiology in real time. Through the Enghoff-modified Bohr equation, physiological dead space can be calculated using the difference between arterial and end-tidal CO₂ (DS = (PaCO₂ - EtCO₂)/PaCO₂). This approach allows clinicians to quantify dead space without requiring invasive or complex instrumentation beyond standard ICU monitoring tools.

Previous research has identified an association between elevated dead space ventilation and increased mortality in conditions such as acute respiratory distress syndrome (ARDS), sepsis, and severe pneumonia. However, the utility of this parameter as a bedside prognostic tool in routine ICU practice remains limited by the lack of prospective validation and standardized monitoring protocols. Moreover, static measurements at a single time point may be insufficient to capture the clinical trajectory of critically ill patients, whereas trend analysis could provide more meaningful prognostic information.

This prospective observational study is designed to evaluate the relationship between physiological dead space and clinical outcomes, specifically ICU mortality and discharge disposition, in adult patients undergoing invasive mechanical ventilation. The study is conducted in a tertiary university hospital ICU and includes adult patients (≥18 years) who meet predefined inclusion criteria. Exclusion criteria are applied to eliminate potential confounders such as patients with noninvasive ventilation, pediatric cases, or those with significant technical limitations affecting capnographic measurements.

Data collection includes demographic characteristics, comorbidities, primary ICU admission diagnoses, ventilator parameters (tidal volume, PEEP, respiratory rate, minute ventilation, driving pressure), arterial blood gas values (PaO₂/FiO₂, PaCO₂), sedation level (RASS), vasoactive medication use, and daily volumetric capnography measurements (EtCO₂). Dead space values are recorded using standardized measurement windows, and time-series analysis is performed based on repeated observations during the ICU stay. The mode of discharge (survival, death, or transfer) is also documented.

The study aims to determine whether physiological dead space at ICU admission and its progression over time can serve as a reliable predictor of outcome. Additionally, it explores the feasibility of incorporating capnography-based dead space assessment into routine ICU monitoring as a noninvasive tool for early prognostication and ventilation optimization. Findings from this study may support broader use of volumetric capnography in intensive care medicine and contribute to individualized patient care strategies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Invasive Mechanical Ventilation Ventilation-Perfusion Mismatch ICU Mortality Critical Illness End Tidal CO2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mechanically Ventilated Adult ICU Patients

Adult patients (aged ≥18 years) who received invasive mechanical ventilation in a tertiary intensive care unit. All participants were prospectively monitored with volumetric capnography and arterial blood gas analysis to evaluate physiological dead space. No interventions were applied as part of the study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to the intensive care unit
* Receiving invasive mechanical ventilation
* Monitored with volumetric capnography and arterial blood gas analysis
* Informed consent obtained from legal representatives

Exclusion Criteria

* Patients under 18 years of age
* ICU length of stay less than 24 hours
* Patient or legal representative refused participation
* Hemoglobin level \< 7 g/dL
* Arterial PaCO₂ \> 70 mmHg
* Signs of circulatory failure
* Lactate \> 4 mmol/L
* Capillary refill time \> 3 seconds
* PaCO₂ - Central venous CO₂ gradient \> 8 mmHg (if applicable)
* Mean arterial pressure (MAP) \< 65 mmHg
* Mottling score ≥ 2
* Body temperature \> 38°C
* Arterial pH \< 7.20
* Body mass index (BMI) \> 40 kg/m²
* Carbon dioxide production (VCO₂) \> 4 mL/kg
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karadeniz Technical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

A. Oguzhan KUCUK

MD, Assist. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mehtap Pehlivanlar Kucuk, MD, Assoc. Prof.

Role: PRINCIPAL_INVESTIGATOR

Karadeniz Technical University, Faculty of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karadeniz Technical University

Trabzon, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/154

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.